Primary non-small-cell lung cancer: Analysis of the des 419 T1 (3 cm) tumors in the KBP-2000-CPHG study;Le cancer bronchique primitif non à petites cellules: Analyse des 419 cas de tumeurs T1 (≤ 3 cm) de l'étude KBP-2000-CPHG

Revue de Pneumologie Clinique

Volumn 60, Issue 6 I, 2004, Pages 333-343

  Collon, T ^a   Ba, O ^a   Grivaux, M ^b   Dore, P ^c   Azarian, R ^d   Orion, B ^e   Boyer, J ^f   Raffy, O ^g   Jourdain, B ^h   Beraud, A ⁱ   Paillot, N ^j   Jouveshomme, S ^k   Mordacque, C ^l   Zureik, M ^m   Marsal, L ⁿ   Piquet, J ^a   Blanchon, F ^b  

^a Hopital Le Raincy Monrtfermeil   (France)

^b CENTRE HOSPITALIER DE MEAUX   (France)

^c Hôpital de la Rochelle   (France)

^d CENTRE HOSPITALIER DE VERSAILLES   (France)

^e Hôpital de Saverne   (France)

^f CHG de Vienne   (France)

^g Hôpital de Chartres   (France)

^h Hôpital de Melun   (France)

ⁱ Hôpital de Thionville   (France)

^j Centre Hospitalier Régional de Metz Thionville   (France)

^k CENTRE HOSPITALIER INTERCOMMUNAL   (France)

^l Hôpital de Béthune

^m INSERM   (France)

ⁿ HÔTEL DIEU   (France)

more..

Author keywords

Adenocarcinoma; Neoadjuvant chemotherapy; Primary non small cell lung cancer; T1 tumors

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRONCHUS BIOPSY; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; PROGNOSIS; SEX RATIO;

EID: 20944433470     PISSN: 07618417     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0761-8417(04)72146-x     Document Type: Article

References (29)

1. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-7.
2. Patz EF Jr, Rossi S, Harpole DH Jr, Herndon JE, Goodman PC. Correlation of tumor size and survival in patients with stage 1A non-small cell lung cancer. Chest 2000;117:1568-71.
3. Heyneman LE, Herndon JE, Goodman PC, Patz EF Jr. Stage distribution in patients with a small (< or = 3 cm) primary non-small cell lung carcinoma. Implication for lung carcinoma screening. Cancer 2001;92:3051-5.
4. Mori K, Tominaga K, Hirose T, Sasagawa M, Yokoyama K, Moriyama N. Utility of low-dose helical CT as a second step after plain chest radiography for mass screening for lung cancer. J Thorac Imaging 1997;12:173-80.
5. Peck K, Sher YP, Shih JY, Roffler SR, Wu CW, Yang PC. Detection and quantitation of circulating cancer cells in the peripheral blood of lung cancer patients. Cancer Rex 1998;58:2761-5.
6. Pantel K, Izbicki J, Passlick B, Angstwurm M, Haussinger K, Thetter O, et al. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet 1996;347:649-53.
7. Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999;284:1994-8.
8. Blanchon F, Grivaux M, Collon T, Zureik M, Barbieux H, Benichou-Flurin M, et al. Epidémiologie du cancer bronchique primitif pris en charge dans les centres hospitaliers généraux français. Rev Mal Respir 2002;19:727-34.
9. Grivaux M, Breton JL, Bombaron P, Kuntz P, Lebas FX, Medahoui A, et al. Lung cancer among women in 2000 in France. Analysis of the 904 female cases of the KBP-2000-CPHG study of the College of Pneumologists of the General Hospitals (CPHG). Lung Cancer 2004;45:279-87.
10. Zhang D, Zhang R, Cheng G. The surgical treatment of lung cancer: a retrospective analysis of 2004 cases. Chin Med J (Engl) 1999;112:25-8.
11. Lopez-Encuentra A, Duque-Medina JL, Rami-Porta R, De La Camara AG, Ferrando P. Staging in lung cancer: is 3 cm a prognostic threshold in pathologic stage I non-small cell lung cancer? A multicenter study of 1020 patients. Chest 2002;121:1515-20.
12. Jung KJ, Lee KS, Kim H, Kwon OJ, Kim J, Shim YM, et al. T1 lung cancer on CT: frequency of extrathoracic metastases. J Comput Assist Tomogr 2000;24:711-8.
13. Yoshida J, Nagai K, Yokose T, Takahashi K, Nishimura M, Goto K, et al. Primary peripheral lung carcinoma smaller than 1 cm in diameter. Chest 1998;114:710-2.
14. Watanabe S, Oda M, Go T, Tsunezuka Y, Ohta Y, Watanabe Y. et al. Should mediastinal nodal dissection be routinely under-taken in patients with peripheral small-sized (2 cm or less) lung cancer? Retrospective analysis of 225 patients. Eur J Cardiothorac Surg 2001;20:1007-11.
15. Charloux A, Quoix E, Wolkove N, Small D, Pauli G, Kreisman H. The increasing incidence of lung adenocarcinoma: reality or artefact? A review of the epidemiology of lung adenocarcinoma. Int J Epidemiol 1997;26:14-23.
16. Depierre A, Milleron B, Moro-Sibilot D, Chevret S, Quoix E, Lebeau B, et al., for the French Thoracic Cooperative Group. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0). 11. and IIIA non-small-cell lung cancer. J Clin Oncol 2002;20:247-53.
17. Scagliotti GV, Fossati R, Torn V, Crino L, Giaccone G, Silvano G, et al., for the Adjuvant Lung Project Italy/European Organisation for Research Treatment of Cancer-Lung Cancel-Cooperative Group Investigators. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell lung cancer. J Natl Cancer Inst 2003;95:1453-61.
18. Arriagada R, Bergman B, Dunant A, Le Chevalier T, Pignon JP, Vansteenkiste J, for the International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004;550:351-60.
19. Smythe WR, for the American College of Chest Physicians. Treatment of stage I non-small cell lung carcinoma. Chest 2003;123:181S-7S.
20. Miller DL, Rowland CM, Deschamps C, Allen MS, Trastek VF, Pairolero PC. Surgical treatment of non-small cell lung cancer 1 cm or less in diameter. Ann Thorac Surg 2002;73:1545-51.
21. Marom EM, Sarvis S, Herndon JE 2nd, Patz EF Jr. T1 lung cancers: sensitivity of diagnosis with fluorodeoxyglucose PET. Radiology 2002;223:453-9.
22. Bernard A, Binquet C, Lejeune C, Hagry O, Quantin C, Faivre J, et al. Gestion diagnostique d'un nodule isolé de plus de 2 cm de diamètre. Rev Mal Respir 2002;19:569-76.
23. Marchetti A, Tinari N, Buttitta F, Chella A, Angeletti CA, Sacco R, et al. Expression of 90K (Mac-2 BP) correlates with distant metastasis and predicts survival in stage 1 non-small cell lung cancer patients. Cancer Res 2002;62:2535-9.
24. Cangemi V, Volpino P, D'Andrea N, Puopolo M, Fabrizi S, Lonardo MT, et al. Local and/or distant recurrences in T1-2/N0-1 non-small cell lung cancer. Eur J Cardiothorac Surg 1995;9:473-8.
25. Deslauriers J, Gregoire J. Surgical therapy of early non-small cell lung cancer. Chest 2000;117:104S-9S.
26. Mountain CF, Lukeman JM, Hammar SP, Chamberlain DW, Coulson WF, Page DL, et al. Lung cancer classification: the relationship of disease extent and cell type to survival in a clinical trials population. J Surg Oncol 1987;35:147-56.
27. Read RC, Yoder G, Schaeffer RC. Survival after conservative resection for T1N0M0 non-small cell lung cancer. Ann Thorac Surg 1990;49:391-400.
28. Salvatierra A, Baamonde C, Llamas JM, Cruz F, Lopez-Pujol J. Extrathoracic staging of bronchogenic carcinoma. Chest 1990;97:1052-8.
29. Yamanaka A, Isowa N, Kiyotani T. [Studies of resected small lung cancer associated with intrapulmonary metastasis]. Kyobu Geka 1991;44:77-80.